TCMD - NASDAQ

Tactile Systems Technology, Inc.

TCMD·NASDAQ

$24.37

-0.16%

HealthcareMedical - Devices

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$549.70M

EPS0.8300

P/E Ratio29.36

Earnings Date08/03/2026

273.94M

Assets

-8%

3Y+7.0%

5Y+57.0%

10Y+271.0%

55.04M

Total Liabilities

-32%

3Y-59.0%

5Y+12.0%

10Y+285.0%

218.90M

Total Equity

3Y+80.0%

5Y+75.0%

10Y+267.0%

Tactile Systems Technology, Inc. Funding & Solvency Profile

TCMD · NASDAQ

Current Assets

Cash & Cash Equivalents83.45M

Net Receivables43.88M

Inventory14.03M

Other Current Assets23.82M

Total Current Assets165 M

Non-Current Assets

Property, Plant & Equipment18.91M

Goodwill & Intangible Assets70.23M

Long-Term Investments0.00

Other Non-Current Assets9.85M

Total Non-Current Assets29 M

Total Assets

273.94M

Financial Health Analysis

Current Ratio

4.03x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.25x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

124 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

60% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Tactile Systems Technology, Inc. Balance Sheet

TCMD • NASDAQ

Tactile Systems Technology, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	83.4M	94.4M	61M	21.9M	28.2M	47.9M	22.8M	20.1M	24M	30.7M	7.1M	5.4M	6.5M
Short-Term Investments	0.0	14.5M	14.2M	16.1M	12.5M	10.7M	30.6M	25.8M	19.9M	11M	0.0	0.0	0.0
Cash & Short-Term Investments	83.4M	108.9M	75.2M	38.1M	40.7M	58.6M	53.4M	45.9M	43.9M	41.7M	7.1M	5.4M	6.5M
Net Receivables	43.9M	44.9M	43.2M	54.8M	49.5M	43.8M	33.4M	26.1M	19.7M	15M	14.2M	13.7M	9.6M
Accounts Receivables	43.9M	44.9M	43.2M	54.8M	49.5M	43.8M	33.4M	24.3M	17.6M	15M	14.2M	13.7M	9.6M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8M	2.1M	0.0	0.0	0.0	0.0
Inventory	14M	18.7M	22.5M	23.1M	19.2M	18.6M	19.1M	11.2M	11M	6.6M	5.8M	3.5M	2.9M
Prepaids	0.0	0.0	0.0	0.0	4.1M	2.6M	2.5M	0.0	0.0	981K	602K	423K	298K
Other Current Assets	23.8M	5.1M	4.4M	3.8M	0.0	0.0	0.0	1.8M	2.2M	981K	1.8M	2M	3.5M
Total Current Assets	165.2M	177.6M	145.3M	119.8M	113.5M	123.6M	108.3M	85M	76.9M	64.2M	29.4M	25.1M	22.8M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	18.9M	22.2M	25.3M	27.4M	30.7M	27.1M	23.3M	4.8M	3.8M	1.6M	1.3M	1.3M	1.4M
Goodwill	31.1M	31.1M	31.1M	31.1M	31.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	39.2M	42.8M	46.7M	50.4M	54.1M	1.7M	5.3M	5.3M	2.2M	2.4M	2.5M	2.7M	3M
Goodwill & Intangible Assets	70.2M	73.9M	77.8M	81.4M	85.1M	1.7M	5.3M	5.3M	2.2M	2.4M	2.5M	2.7M	3M
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9M	2.7M	2.8M	2M	1.3M	921K
Tax Assets	9.8M	18.3M	19.4M	0.0	0.0	10.2M	9M	8.8M	2.7M	2.8M	402K	1M	1.1M
Other Non-Current Assets	9.8M	6M	13.7M	26.4M	14.8M	11.5M	5.8M	1.3M	201K	137K	1.3M	23K	23K
Total Non-Current Assets	108.8M	120.4M	136.1M	135.2M	130.7M	50.5M	43.4M	22.1M	11.6M	9.7M	7.6M	6.4M	6.4M
Total Assets	273.9M	297.9M	281.4M	255M	244.3M	174.1M	151.8M	107.1M	88.4M	73.9M	37M	31.5M	29.2M
LIABILITIES
CURRENT LIABILITIES
Total Payables	5M	6.7M	8.3M	12.5M	5.1M	7M	4.7M	5.2M	5.5M	4.6M	4.2M	2.6M	2.1M
Accounts Payable	5M	5.6M	6.7M	10M	5M	4.2M	3.8M	5.1M	4.3M	3.8M	3.3M	2.5M	2M
Other Payables	0.0	1.1M	1.7M	2.5M	122K	2.9M	832K	115K	1.3M	824K	904K	100K	171K
Accrued Expenses	0.0	24.9M	22.5M	26.2M	17.3M	14.2M	13.2M	0.0	0.0	0.0	0.0	0.0	0.0
Short Term Debt	3.2M	3M	3M	3M	3M	0.0	0.0	5K	17K	67K	991K	9K	8K
Capital Lease Obligations (Current)	0.0	3M	2.8M	2.5M	2.5M	2M	1.5M	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	1.4M	1.1M	1.7M	2.5M	122K	2.9M	832K	51K	1.1M	823K	904K	100K	171K
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-5K	-17K	-67K	-991K	2.8M	3.3M
Other Current Liabilities	32.8M	3.1M	4.5M	20.2M	6.6M	3.4M	2.1M	11M	10.3M	8.8M	6.2M	924K	378K
Total Current Liabilities	41M	40.7M	41.1M	64.3M	34.5M	26.7M	21.4M	16.1M	14.5M	13.8M	9.5M	6.2M	5.7M
NON-CURRENT LIABILITIES
Long Term Debt	12.8M	23.2M	26.2M	45.9M	51.8M	0.0	0.0	0.0	0.0	0.0	0.0	4K	14K
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	32K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	1.3M	1.4M	2.1M	2.5M	6.4M	3.2M	2.6M	1.7M	1.1M	503K	193K	645K	1.4M
Total Non-Current Liabilities	14.1M	40.6M	46.7M	69.3M	81.6M	22.6M	17.7M	1.7M	1.1M	503K	193K	649K	1.4M
Capital Lease Obligations	0.0	18.9M	21.2M	23.4M	25.9M	21.4M	16.6M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	55M	81.3M	87.8M	133.6M	116M	49.3M	39.2M	17.8M	15.7M	14.3M	9.7M	6.8M	7M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-493K	0.0	0.0	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9M	31.1M	29.3M
Common Stock	22K	24K	24K	20K	20K	19K	19K	19K	18K	17K	3K	7K	6K
Additional Paid-In Capital	0.0	180.7M	174.7M	131M	120M	104.7M	91.9M	0.0	70.2M	0.0	0.0	0.0	0.0
Retained Earnings	54.9M	35.9M	18.9M	-9.6M	8.2M	20.1M	20.7M	9.7M	3.1M	-2.8M	-5.7M	-6.9M	-8.9M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	26K	-8K	-44K	-11K	-2.2M	-1.6M	-1.2M
Other Total Stockholders' Equity	163.9M	0.0	0.0	0.0	0.0	0.0	0.0	79.6M	0.0	62.4M	2.2M	2M	3M
Total Stockholders' Equity	218.9M	216.6M	193.6M	121.4M	128.2M	124.8M	112.6M	89.3M	72.8M	59.6M	27.3M	24.7M	22.2M
Total Equity	218.9M	216.6M	193.6M	121.4M	128.2M	124.8M	112.6M	89.3M	72.8M	59.6M	27.3M	24.7M	22.2M
SUMMARY
Total Liabilities & Equity	273.9M	297.9M	281.4M	255M	244.3M	174.1M	151.8M	107.1M	88.4M	73.9M	37M	31.5M	29.2M
Total Investments	0.0	14.5M	14.2M	16.1M	12.5M	10.7M	30.6M	27.7M	22.7M	11M	2M	1.3M	921K
Total Debt	16M	45.1M	50.4M	72.2M	80.6M	21.4M	16.6M	5K	17K	67K	991K	13K	22K
Net Debt	-67.5M	-49.3M	-10.7M	50.3M	52.4M	-26.5M	-6.2M	-20.1M	-24M	-30.6M	-6.1M	-5.4M	-6.5M
Shares Outstanding	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582	22,335,582

SEC Filings

TCMD - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 07, 2026	May 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 25, 2026	May 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 09, 2026	March 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 17, 2026	December 31, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 03, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 03, 2025	November 03, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 04, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 143 filings

Related Guides

Blog Categories

Continue your TCMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.